JPRN-jRCT2080221883未知2 期
A clinical study to evaluate the safety, tolerability, antiviral activity, and pharmacokinetics of ABT-450 with Ritonavir (ABT-450/r) and ABT-267 in treatment experienced Japanese adults with chronic Hepatitis C Virus infection
试验速览
- 阶段
- 2 期
- 发起方
- AbbVie GK
- 入组人数
- 96
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 75age old（—）
- 性别
- All
入选标准
- •Male or female between the age 18 and 75 years, inclusive.
- •-Previously received Pegylated interferon alpha-2a/Ribavirin.
- •-Chronic hepatitis C virus infection.
- •-Plasma hepatitis C virus ribonucleic acid level greater than 10,000 International Units/milliliter.
- •-Voluntarily sign an informed consent.
排除标准
- •-Histry of severe, life-threatening sensitivity to any drug.
- •-Females who are pregnant or plan to become pregnant, or breastfeeding.
- •-Recent histry of drug or alcohol abuse.
- •-Positive test result for hepatitis B surface antigen or anti-Human immunodeficiency virus antibodies.
- •-Any current or past clinical evidence of cirrhosis.
- •-Previous use of any investigational or commerciallyavailable anti-Hepatitis C virus agent other than Pegylated interferon alpha-2a and Ribavirin, including previous exposure to ABT-450 or ABT-267.
研究者
相似试验
招募中
不适用
safety and effectiveness of Soreze gel in pressure ulcerCTRI/2021/06/034297Amaterasu Lifesciences
已完成
不适用
A clinical study to evaluate the safety, tolerability, and pharmacokinetics of the MMP 12 inhibitor FP- 025 after multiple oral ascending dose administration, and to evaluate the effect of food after a single oral dose administration in healthy subjectsasthmaNL-OMON44633Foresee Pharmaceuticals Co., Ltd.32
已完成
不适用
A clinical trial to evaluate the safety, tolerability, and pharmacokinetics of single and multiple ascending oral doses of LEO 153339 in healthy subjectsPsoriasisNL-OMON51974eo Pharma A/S134
尚未招募
1 期
A single center clinical study of evaluating the injection of microRNA2911 plasmid in healthy adultsovel Coronavirus Pneumonia (COVID-19)ITMCTR2000003169anjing University
已完成
2 期
Clinical study to investigate safety, tolerability, efficacy,pharmacokinetics and pharmacodynamics of inhaled multiple doses of the human GATA-3-specific DNAzyme solution SB010 in patients with moderate to severe COPD– A randomised, double-blind, parallel group, multicenter, phase IIa pilot study –J44.9Chronic obstructive pulmonary disease, unspecifiedDRKS00006087Philipps-Universität Marburg19